184 related articles for article (PubMed ID: 3415257)
21. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
22. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas.
Comandone A; Bretti S; Bertetto O; Oliva C; Bergnolo P; Bumma C
Anticancer Res; 2000; 20(3B):2077-80. PubMed ID: 10928155
[TBL] [Abstract][Full Text] [Related]
23. [Multidisciplinary treatment of bone and soft tissue sarcomas].
Furuya K; Wada N; Kawaguchi N; Amino K
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1063-72. PubMed ID: 4057570
[TBL] [Abstract][Full Text] [Related]
24. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
25. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
26. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
27. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy.
Lehti PM; Moseley HS; Janoff K; Stevens K; Fletcher WS
Surg Gynecol Obstet; 1986 Feb; 162(2):149-52. PubMed ID: 3945892
[TBL] [Abstract][Full Text] [Related]
28. Feasibility study of postoperative adjuvant chemotherapy and radiotherapy for soft-tissue sarcoma.
Fuchs R; Schadeck-Gressel C; Makoski HB; von Andrian-Werburg HF; Knieriem HJ; Westerhausen M
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S199-203. PubMed ID: 8453698
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
Nooij MA; Whelan J; Bramwell VH; Taminiau AT; Cannon S; Hogendoorn PC; Pringle J; Uscinska BM; Weeden S; Kirkpatrick A; Glabbeke Mv; Craft AW;
Eur J Cancer; 2005 Jan; 41(2):225-30. PubMed ID: 15661546
[TBL] [Abstract][Full Text] [Related]
31. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of soft tissue sarcomas of the hand and foot.
Lin PP; Guzel VB; Pisters PW; Zagars GK; Weber KL; Feig BW; Pollock RE; Yasko AW
Cancer; 2002 Aug; 95(4):852-61. PubMed ID: 12209730
[TBL] [Abstract][Full Text] [Related]
33. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.
Taki J; Sumiya H; Higuchi T; Tsuchiya H; Takazawa K; Tomita K; Tonami N
J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547
[TBL] [Abstract][Full Text] [Related]
34. [Continuous intra-arterial infusion chemotherapy for malignant bone and soft tissue tumors in pelvis and trunk areas].
Kushida Y; Takeuchi S; Kasai C; Satoh M; Nishimoto Y; Kawai A
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1777-82. PubMed ID: 2389964
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors of bone and soft tissue sarcomas].
Furuse K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2050-5. PubMed ID: 3293534
[TBL] [Abstract][Full Text] [Related]
37. [Solid tumors in young patients].
Hartmann JT; Lorch A
Onkologie; 2011; 34 Suppl 5():12-6. PubMed ID: 21921662
[No Abstract] [Full Text] [Related]
38. [Procedures and results of limb salvage surgery of musculoskeletal sarcoma].
Kawaguchi N; Amino K; Matsumoto S; Manabe J; Isobe Y; Furuya K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1154-63. PubMed ID: 3382192
[TBL] [Abstract][Full Text] [Related]
39. [Application of preoperative chemotherapy to postoperative chemotherapy in malignant bone and soft tissue tumors].
Furuse K; Morimoto K; Yamamoto K; Orito T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1749-54. PubMed ID: 2730070
[TBL] [Abstract][Full Text] [Related]
40. [99mTc-MAA perfusion studies in the treatment of preoperative intra-arterial infusion chemotherapy of malignant bone and soft tissue sarcoma].
Satoh M; Takeuchi S; Kasai C; Kushida Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2359-65. PubMed ID: 3415248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
